111 related articles for article (PubMed ID: 3859238)
21. Solution conformation of the (-)-cis-anti-benzo[a]pyrenyl-dG adduct opposite dC in a DNA duplex: intercalation of the covalently attached BP ring into the helix with base displacement of the modified deoxyguanosine into the major groove.
Cosman M; Hingerty BE; Luneva N; Amin S; Geacintov NE; Broyde S; Patel DJ
Biochemistry; 1996 Jul; 35(30):9850-63. PubMed ID: 8703959
[TBL] [Abstract][Full Text] [Related]
22. On the molecular mechanism of drug intercalation into DNA: a simulation study of the intercalation pathway, free energy, and DNA structural changes.
Mukherjee A; Lavery R; Bagchi B; Hynes JT
J Am Chem Soc; 2008 Jul; 130(30):9747-55. PubMed ID: 18611009
[TBL] [Abstract][Full Text] [Related]
23. The interaction with DNA of unfused aromatic systems containing terminal piperazino substituents. Intercalation and groove-binding.
Wilson WD; Barton HJ; Tanious FA; Kong SB; Strekowski L
Biophys Chem; 1990 Apr; 35(2-3):227-43. PubMed ID: 2397274
[TBL] [Abstract][Full Text] [Related]
24. Conformation and dynamics of drug-DNA intercalation.
Herzyk P; Neidle S; Goodfellow JM
J Biomol Struct Dyn; 1992 Aug; 10(1):97-139. PubMed ID: 1418749
[TBL] [Abstract][Full Text] [Related]
25. Acridinecarboxamide topoisomerase poisons: structural and kinetic studies of the DNA complexes of 5-substituted 9-amino-(N-(2-dimethylamino)ethyl)acridine-4-carboxamides.
Adams A; Guss JM; Collyer CA; Denny WA; Prakash AS; Wakelin LP
Mol Pharmacol; 2000 Sep; 58(3):649-58. PubMed ID: 10953060
[TBL] [Abstract][Full Text] [Related]
26. Daunomycin intercalation stabilizes distinct backbone conformations of DNA.
Trieb M; Rauch C; Wellenzohn B; Wibowo F; Loerting T; Mayer E; Liedl KR
J Biomol Struct Dyn; 2004 Apr; 21(5):713-24. PubMed ID: 14769064
[TBL] [Abstract][Full Text] [Related]
27. Molecular modeling to study DNA intercalation by anti-tumor drugs.
Neidle S; Jenkins TC
Methods Enzymol; 1991; 203():433-58. PubMed ID: 1762566
[No Abstract] [Full Text] [Related]
28. Stopped-flow kinetic analysis of the interaction of anthraquinone anticancer drugs with calf thymus DNA, poly[d(G-C)].poly[d(G-C)], and poly[d(A-T)].poly[d(A-T)].
Krishnamoorthy CR; Yen SF; Smith JC; Lown JW; Wilson WD
Biochemistry; 1986 Oct; 25(20):5933-40. PubMed ID: 3790495
[TBL] [Abstract][Full Text] [Related]
29. Influence of aglycone modifications on the binding of anthracycline drugs to DNA: the molecular structure of idarubicin and 4-O-demethyl-11-deoxydoxorubicin complexed to d(CGATCG).
Gao YG; Wang AH
Anticancer Drug Des; 1991 Jul; 6(3):137-49. PubMed ID: 1872945
[TBL] [Abstract][Full Text] [Related]
30. New ruthenium(II) arene complexes of anthracenyl-appended diazacycloalkanes: effect of ligand intercalation and hydrophobicity on DNA and protein binding and cleavage and cytotoxicity.
Ganeshpandian M; Loganathan R; Suresh E; Riyasdeen A; Akbarsha MA; Palaniandavar M
Dalton Trans; 2014 Jan; 43(3):1203-19. PubMed ID: 24177707
[TBL] [Abstract][Full Text] [Related]
31. Anthracycline antibiotic arugomycin binds in both grooves of the DNA helix simultaneously: an NMR and molecular modelling study.
Searle MS; Bicknell W; Wakelin LP; Denny WA
Nucleic Acids Res; 1991 Jun; 19(11):2897-906. PubMed ID: 1647521
[TBL] [Abstract][Full Text] [Related]
32. Binding free energy of selected anticancer compounds to DNA--theoretical calculations.
Baginski M; Polucci P; Antonini I; Martelli S
J Mol Model; 2002 Jan; 8(1):24-32. PubMed ID: 12111399
[TBL] [Abstract][Full Text] [Related]
33. Docking studies on DNA intercalators.
Gilad Y; Senderowitz H
J Chem Inf Model; 2014 Jan; 54(1):96-107. PubMed ID: 24303988
[TBL] [Abstract][Full Text] [Related]
34. A-form conformational motifs in ligand-bound DNA structures.
Lu XJ; Shakked Z; Olson WK
J Mol Biol; 2000 Jul; 300(4):819-40. PubMed ID: 10891271
[TBL] [Abstract][Full Text] [Related]
35. The interaction between the novel intercalator diethidium cation and B-form DNA: a theoretical study.
Monaco RR; Polkosnik W
J Biomol Struct Dyn; 1996 Aug; 14(1):13-9. PubMed ID: 8877557
[TBL] [Abstract][Full Text] [Related]
36. [Study of the properties of condensed forms of the complexes of linear and supercoiled DNA with mitoxantrone and bisantrene].
Salianov VI; Evdokimov IuM; Palumbo M
Antibiot Khimioter; 1990 Jan; 35(1):19-22. PubMed ID: 2334240
[TBL] [Abstract][Full Text] [Related]
37. Minor groove binding of SN6999 to an alkylated DNA: molecular structure of d(CGC[e6G]AATTCGCG)-SN6999 complex.
Gao YG; Sriram M; Denny WA; Wang AH
Biochemistry; 1993 Sep; 32(37):9639-48. PubMed ID: 8373768
[TBL] [Abstract][Full Text] [Related]
38. Solution conformation of [AF]dG opposite a -2 deletion site in a DNA duplex: intercalation of the covalently attached aminofluorene ring into the helix with base displacement of the C8-modified syn guanine and adjacent unpaired 3'-adenine into the major groove.
Mao B; Hingerty BE; Broyde S; Patel DJ
Biochemistry; 1995 Dec; 34(51):16641-53. PubMed ID: 8527437
[TBL] [Abstract][Full Text] [Related]
39. Spectroscopic studies of the effects of anticancer drug mitoxantrone interaction with calf-thymus DNA.
Agarwal S; Jangir DK; Mehrotra R
J Photochem Photobiol B; 2013 Mar; 120():177-82. PubMed ID: 23266050
[TBL] [Abstract][Full Text] [Related]
40. Characteristics of the binding of the anticancer agents mitoxantrone and ametantrone and related structures to deoxyribonucleic acids.
Lown JW; Morgan AR; Yen SF; Wang YH; Wilson WD
Biochemistry; 1985 Jul; 24(15):4028-35. PubMed ID: 4052381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
